Gain of chromosome 1q and MYCN characterize unique subgroups of Asian Wilms tumor patients

Read full text Summarise with VIRAT
Authors: Meng Kang Wong, Kia Teng Lim, Đỗ Thị Ngọc Thùy, Phan Đặng Anh Thư, Sheng Hui Tan, Isshani Devaraj, Chik Hong Kuick, Sharon Ling, Min Hwee Yong, Kenneth T.E. Chang, Khawn D. Tawng, Prasad Iyer
+7 more Shui Yen Soh, York Tien Lee, Siam Wee Sim, Eric Yew Meng Yeo, Victor K.M. Lee, Chí Bảo Bùi, Amos Hong Pheng Loh
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Wilms tumors in Asian populations demonstrate uniquely favorable biological characteristics and are not appropriately stratified by current risk markers like loss of heterozygosity of 1p and 16q. We analyzed the prognostic associations of copy number changes at other genomic loci in a population-based cohort of Wilms tumor and explored genomic profiles of relapsed cases. Chromosomal aberrations of targeted loci were evaluated in 61 Wilms tumors treated with National Wilms Tumor Study regimens in Singapore hospitals from 2001-2022, and 26 tumors from a separate Asian validation set, and correlated with clinical variables. Mutational signatures of 6 relapsed patients' tumors were profiled using whole-exome sequencing. Clustering analysis identified a subgroup (65.6 %) of predominantly non-Asian patients with higher frequency of relapse, 1p and 16q loss and 1q gain. A smaller predominantly-Asian subgroup (34.4 %) with low stage and few relapses was characterized by gain of MYCN and minimal 1p, 1q and 16q aberrations. MYCN exon 2 gain was present in 9.8 % of the discovery set and 11.5 % of the validation set. Loss of IGF2 and 1p gene ABCA4, and gain of 1q genes, were associated with relapse. Notably, relapsed tumors demonstrated no recurrent somatic mutations; instead, in 2 patients with 1q gain clonal deconvolution showed persistence of chemo-refractory clones without metachronous pathogenic variants. Among Asian Wilms tumor patients, 1q gain is prognostic for relapse. Gain of MYCN features uniquely in Asian patients and may represent a favorable prognostic marker. These results identify distinct molecular subgroups associated with varying prognosis and relapse among Asian patients.

Fields of Study & Subjects

Renal and related cancers Sarcoma Diagnosis and Treatment Chromatin Remodeling and Cancer

Publication details

Journal / source
Cancer Treatment and Research Communications
Volume
47
Pages
101191–101191
Publication date
1 January 2026
Language
EN